Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response. - Wikidata - awgldk - TriplyDB

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

http://www.wikidata.org/entity/Q37068835

about

MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs Androgen receptor molecular biology and potential targets in prostate cancer PHD2: from hypoxia regulation to disease progression Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen Receptor Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers.Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs.The role of MAGEA2 in head and neck cancer.Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.Human prolyl hydroxylase expression in uterine leiomyoma during the menstrual cycle.miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.Establishment of MAGEC2-knockout cells and functional investigation of MAGEC2 in tumor cells.Chlamydia trachomatis-induced alterations in the host cell proteome are required for intracellular growth.Prolyl-hydroxylase 3: Evolving Roles for an Ancient Signaling Protein Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability.Cancer testis antigens: a novel target in lung cancer.The MAGE protein family and cancer.Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines.Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis.Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy

P2860

Q24298306-7B649E31-4C22-4E8F-BBB2-8F70E922DCF4 Q24602861-34C98E93-17DF-40A1-A4AE-9D75FB286E0E Q28069316-ED219065-D77B-4ADB-B1BA-B015F2EAB8DB Q29040033-FBBA84D0-353A-4147-AF9E-BC9825732899 Q33555751-B41537EF-4D27-4DA4-9731-51546EDA0156 Q34074238-35EEF0D1-795F-4AE2-922F-1A9D375A3C83 Q35844503-0318AC9E-6865-4554-825F-D1A5A4B65120 Q35993412-7DDD3699-D82C-4438-B84A-6825E4464265 Q36594429-FFEDA21D-C6D0-4417-AD19-5B19344BA67B Q37405030-0F15F8C2-F4CE-4BE9-8F28-2D13F0A82D72 Q37544387-51B9DB86-EB89-408B-B852-8C33039836CA Q37598672-4F3E1A7E-D896-4129-9C55-2784F6E29B44 Q37657590-3ED0954A-6423-4CE3-8697-4A76F4A82080 Q38053488-4E30DC42-D79D-4D79-981B-8420FA827E86 Q38053489-0AEF7380-EFEE-4D5E-8E51-8CA75BDAD717 Q38581531-C4B0B70C-C4B5-4B90-B075-4CD7938F17D0 Q39399506-42959D31-237F-4729-AFC0-1302959D555D Q39456290-D74A8367-3C30-4723-8DAC-27644A14AB45 Q42267329-1C46A678-2554-4D65-85A8-29271583D3F6

P2860

Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

http://www.wikidata.org/entity/Q37068835

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Melanoma antigen-11 inhibits t ...... nd activates hypoxic response.

@en

Melanoma antigen-11 inhibits t ...... nd activates hypoxic response.

@nl

type

label

Melanoma antigen-11 inhibits t ...... nd activates hypoxic response.

@en

Melanoma antigen-11 inhibits t ...... nd activates hypoxic response.

@nl

prefLabel

Melanoma antigen-11 inhibits t ...... nd activates hypoxic response.

@en

Melanoma antigen-11 inhibits t ...... nd activates hypoxic response.

@nl

P1433

Q37068835-EEEA3708-7BF4-425F-A0D0-C1067586B84A

P1476

Q37068835-C4DC3F6D-77B0-4516-B7FA-9E0BF6A893D5

P2093

Q37068835-69421A36-A117-417C-A0AE-4CAE846931DE

Q37068835-A499AF16-1EB7-49F2-A9C0-77E01C63601F

Q37068835-BDBD07E6-D104-4BC8-868B-4567A3D91D33

Q37068835-C14D6589-CA42-42F8-8250-CD070D4E1CF5

Q37068835-C4A7B56E-002F-47F3-AB27-88EC0B5F65D0

Q37068835-DF5BED72-0962-49A6-A329-9CD065FB525A

Q37068835-EAB88A1C-434D-47FC-BD1D-E83947271DA7

Q37068835-F46084AE-2758-4E55-ABFB-C8744A4B6439

P2860

Q37068835-090A9156-014A-44F7-B73E-22A869B514D9

Q37068835-09166B85-5E7E-4CDD-A13F-23DA0BE56A81

Q37068835-0FFFE2EC-2852-4F81-A7EF-815B8B5986B7

Q37068835-113B6C0A-3E35-49E7-B60A-5579D7BC4113

Q37068835-11E57F38-9294-49E2-9386-FBA8FEA6F16A

Q37068835-1F6AF3C1-06F0-456B-9740-20FA13A0B096

Q37068835-28880614-CCB9-43FE-A92E-CC1077B24222

Q37068835-28C039C7-F5DB-4FF4-A0C8-AAC2BFA70A8C

Q37068835-341321D2-82B1-49E2-8861-F76BB4376472

Q37068835-3BC8420B-5206-43E8-9A31-DBBB502A2D6E

P304

Q37068835-E8577A77-5794-47A0-84C1-4E0F4DC9A957

P31

Q37068835-3B418D76-1AEC-40C8-83A8-254A833BD17D

P356

Q37068835-78DFC9E2-333C-4386-B90C-A6307E337E4B

P407

Q37068835-ACCC66E7-858A-4F24-9C28-6C687D484B60

P433

Q37068835-C5FDA8FD-BB27-42E8-97F9-14AED55D75BC

P478

Q37068835-9A8AE17F-F73D-41AD-A2B3-2D141BBAFB30

P50

Q37068835-B218BAB3-F828-4EDA-8ACC-B8BCC29AD66D

P577

Q37068835-10E3F43F-BAEB-47CF-A0FF-D98E1DBD10EA

P5875

Q37068835-AB9AADF8-AE75-473C-82CB-C5A610FA9D51

P698

Q37068835-F07E64C0-23C0-47AB-8548-AC895D6E9730

P921

Q37068835-5E137F46-19C9-49E4-8BEC-B3CEBFB30A66

P932

Q37068835-A9B56326-9753-4878-AE49-A051324D12C4

P356

0008-5472.CAN-08-0811

P1433

Cancer Research

P1476

Melanoma antigen-11 inhibits t ...... and activates hypoxic response

@en

P2093

J Carl Barrett

http://www.w3.org/2001/XMLSchema#string

John I Risinger

http://www.w3.org/2001/XMLSchema#string

John Niederhuber

http://www.w3.org/2001/XMLSchema#string

Konstantin Salnikow

http://www.w3.org/2001/XMLSchema#string

Mark Ferreira

http://www.w3.org/2001/XMLSchema#string

Olga Aprelikova

http://www.w3.org/2001/XMLSchema#string

Silvia Pandolfi

http://www.w3.org/2001/XMLSchema#string

Yvona Ward

http://www.w3.org/2001/XMLSchema#string

P2860

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

A conserved family of prolyl-4-hydroxylases that modify HIF

FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity

OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha

Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing

MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents

The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

Androgen-dependent gene expression of prostate-specific antigen is enhanced synergistically by hypoxia in human prostate cancer cells

P304

616-624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-0811

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23791521

http://www.w3.org/2001/XMLSchema#string

P698

19147576

http://www.w3.org/2001/XMLSchema#string

P921

P932

2629394

http://www.w3.org/2001/XMLSchema#string